Latest Matter News

Mount Ridley has lodged a second provisional patent application for an adapted Selectro chemistry targeting industrial metal feedstocks, following first-pass bauxite recoveries of 92% aluminium and 97% iron. Gallium results are still pending, and the process has not yet been optimised for bauxite.

Clime Capital has begun a valuation and private debt review after KPMG qualified its FY26 audit over $36.2 million of unlisted unit trusts. The company says it has not identified a material adverse change, but any adjustment to asset values, fees or receivables remains unresolved.

NOVONIX has replaced a binding PowerCo supply agreement covering at least 32,000 tonnes of synthetic graphite with a framework that leaves volume and price unresolved. A new offtake deal will only be negotiated after customer qualification and further certification.

Nyrada has moved its PROTECT-MI heart-attack trial into active recruitment, with four hospitals open and three patients dosed. The biotech also reported supportive US FDA feedback, encouraging preclinical oncology data and AU$13.72 million in cash after a AU$12 million placement.

Skylark Minerals has more than tripled the Inferred Mineral Resource at its Zaranou Gold Project in Côte d’Ivoire to 1.20 million ounces after 2026 drilling at M’Basso. The company has also signed a binding agreement to lift its project interest from 51% to 90% for US$1.2 million.

Sinclair Gold has extended gold mineralisation up to 230 metres beyond the northern Mt Henry resource boundary, including a 0.4-metre interval grading 122.7g/t. Drilling has also identified mineralisation 250 metres south of the main resource, with assays pending from 30 holes.

Falcon Metals has struck 12 metres at 2.8g/t gold from surface in the first hole at its Olsen Well prospect, including 4 metres at 4.7g/t. The result has confirmed bedrock mineralisation beneath a 5.8-kilometre soil anomaly, but four nearby holes were only weakly anomalous and the geometry remains unresolved.

Algorae has secured exclusive Australian commercial rights across eight Umedica-branded molecules while separately advancing a Umedica-supplied product towards regulatory approval. The broader arrangement remains partly non-binding, with financial terms undisclosed and TGA approval still pending.

WA1 Resources has reported broad, high-grade niobium intersections from infill drilling at the eastern zone of its Luni Project, with 41 further assays still pending. The results are intended to support a Q1 CY2027 resource update targeting an initial Measured Resource, while the Pre-Feasibility Study remains on track for completion this quarter.

European Lithium has secured a date for the Supreme Court of Western Australia to consider approval of its proposed acquisition by NASDAQ-listed Critical Metals Corp. Several transaction conditions have been satisfied, waived or appear on track, but securityholder votes and court approval remain outstanding.

Monadelphous Group Limited (ASX:MND) enters FY27 with record FY26 revenue of $2.98 billion, a 52.1% profit increase and more than $680 million of new contracts secured since year-end. The engineering services group is also carrying a disputed claim worth about $200 million and a sizeable exposure to fossil-fuel markets.

Bendigo Bank’s unaudited 1Q27 cash earnings rose 18.5% against the prior half-year quarterly average, but statutory profit fell as net interest margin narrowed and non-cash property revaluations weighed. Deposits grew while lending contracted, with the bank continuing its costly non-financial risk remediation program.